The National Supplier Clearinghouse has provided the following information for pharmacists NOT supplying DMEPOS...
CMS has deemed that suppliers providing drugs and pharmaceuticals only are not required to be accredited to obtain/maintain Medicare billing privileges. If suppliers bill for DMEPOS outside of pharmaceuticals, including products to administer drugs or pharmaceuticals, accreditation will be required to maintain Medicare billing privileges.
Pharmacy suppliers must update their file with the National Supplier Clearinghouse (NSC) by choosing "Pharmacy" as the supplier type in section 2B, and selecting "Drugs/Pharmaceuticals" only in section 2C of the CMS-855S enrollment form. All other products/services must be removed to assume the accreditation exemption.
Suppliers found to be in violation of this rule by billing for other products or services will be subject to appropriate actions up to and including revocation.
Bill Popomaronis, R.Ph., NCPA vice president, home health and long term care pharmacy services, provides his thoughts and explanations on the latest DME information from CMS.
